Good News! Tongee Medical's Gastric Bypass Stent System Has Obtained the Medical Device Registration Certificate in the Philippines!

Recently, the gastric bypass stent system independently developed by Tongee Medical has been officially certified in the Philippines! Since the beginning of the year, Tongee Medical has received continuous good news in overseas markets. The gastric bypass stent system has been successively approved in many countries, and the internationalization process has been continuously accelerated. This is not only an authoritative confirmation of the safety and effectiveness of the product, but also shows that the original Chinese interventional weight loss therapy has been widely recognized by the global market and is gradually growing from an innovative technology to a mainstream solution in the field of global obesity and metabolic disease treatment.

As a leading enterprise in China's metabolic disease interventional therapy, Tongee Medical has always taken it as its mission to "empower health with technology and benefit the world with innovation". It actively responds to the "Belt and Road Initiative" and contributes to the improvement of medical standards in countries along the route with high-quality medical technologies.

Metabolic diseases are prevalent in Southeast Asia, and there is an urgent need for diagnosis and treatment. This region is also a core area for the company's global expansion. After successfully entering Indonesia, Thailand, Vietnam, and Malaysia, the successful expansion into the Philippines market has further completed Tongee Medical's strategic layout in the ASEAN region, forming a multi-point linkage and all-region coverage development trend.

In the future, Tongee Medical will continue to promote the registration and clinical implementation of the gastric bypass stent system in ASEAN and other countries along the "Belt and Road" Initiative, helping to quickly replicate China's mature medical treatment model in overseas regions, allowing more countries and patients to enjoy safe, minimally invasive and efficient Chinese original medical achievements right at their doorstep. Through concrete actions, it will fulfill its corporate responsibility and lead the global obesity and metabolic disease diagnosis and treatment system to achieve high-quality upgrading!